Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce drugs, including a new version of Keytruda, creating 4,500 jobs by 2030, aligning with US d...
Merck & Co. Inc. is investing $1 billion in a new Delaware facility to produce drugs and a new version of Keytruda, creating 4,500 jobs by 2030. This move aligns with a broader tre...
Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce innovative drugs and a new Keytruda formulation, creating 4,500 jobs by 2030, aligning with...
Merck & Co. Inc. announces a $1 billion investment in Delaware for a new facility to produce innovative drugs and a new version of Keytruda, creating 4,500 jobs and aligning with U...
